Filed: 8/14/2024ACC: 0001999371-24-010146
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 91 equity positions with a total reported market value of $867.51M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
91
Positions
$867.51M
Total AUM (reported)
114.12M
Total Shares
Allocation by class
COM$383.63M44.2%
TR UNIT$190.48M22.0%
SPONSORED ADS$65.65M7.6%
COM NEW$44.06M5.1%
SHS$26.24M3.0%
COMMON STOCK$25.39M2.9%
NOTE 2.500% 3/1$17.26M2.0%
Portfolio Concentration
Top 3$271.49M31.3%
4–10$179.48M20.7%
11–25$199.69M23.0%
Rest$216.85M25.0%
Top 3 weight
31.3%
Top 10 weight
52.0%
Voting Authority Distribution
Total shares with voting rights: 114.12M
Sole
Full voting authority
114.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole91
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings91
Rows:
SPDR S&P 500 ETF TR
SOLEShares350K
TypeSH
Market value$190.48M
21.96%
Sole
350K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares2.60M
TypeSH
Market value$42.25M
4.87%
Sole
2.60M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares994.23K
TypeSH
Market value$38.76M
4.47%
Sole
994.23K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares836.28K
TypeSH
Market value$32.91M
3.79%
Sole
836.28K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares110K
TypeSH
Market value$30.82M
3.55%
Sole
110K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares750K
TypeSH
Market value$30.67M
3.54%
Sole
750K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares460K
TypeSH
Market value$25.39M
2.93%
Sole
460K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares515K
TypeSH
Market value$23.07M
2.66%
Sole
515K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares912K
TypeSH
Market value$19.03M
2.19%
Sole
912K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares475.40K
TypeSH
Market value$17.59M
2.03%
Sole
475.40K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares17M
TypePRN
Market value$17.26M
1.99%
Sole
17M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares15M
TypePRN
Market value$16.20M
1.87%
Sole
15M
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares110K
TypeSH
Market value$15.69M
1.81%
Sole
110K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares650K
TypeSH
Market value$15.66M
1.81%
Sole
650K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares200K
TypeSH
Market value$15.17M
1.75%
Sole
200K
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares4.30M
TypeSH
Market value$14.96M
1.72%
Sole
4.30M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares375K
TypeSH
Market value$13.57M
1.56%
Sole
375K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares650K
TypeSH
Market value$13.38M
1.54%
Sole
650K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares2.86M
TypeSH
Market value$12.74M
1.47%
Sole
2.86M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares513.42K
TypeSH
Market value$12.07M
1.39%
Sole
513.42K
Shared
0.00
None
0.00
ELIEM THERAPEUTICS INC
SOLEShares1.67M
TypeSH
Market value$11.88M
1.37%
Sole
1.67M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares400.39K
TypeSH
Market value$10.57M
1.22%
Sole
400.39K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares1.14M
TypeSH
Market value$10.26M
1.18%
Sole
1.14M
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares223.41K
TypeSH
Market value$10.15M
1.17%
Sole
223.41K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares700K
TypeSH
Market value$10.12M
1.17%
Sole
700K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 350K | SH | $190.48M 21.96% | 350K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 2.60M | SH | $42.25M 4.87% | 2.60M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 994.23K | SH | $38.76M 4.47% | 994.23K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 836.28K | SH | $32.91M 3.79% | 836.28K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 110K | SH | $30.82M 3.55% | 110K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 750K | SH | $30.67M 3.54% | 750K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 460K | SH | $25.39M 2.93% | 460K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 515K | SH | $23.07M 2.66% | 515K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 912K | SH | $19.03M 2.19% | 912K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 475.40K | SH | $17.59M 2.03% | 475.40K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 17M | PRN | $17.26M 1.99% | 17M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | NOTE 1.000% 9/1 | 15M | PRN | $16.20M 1.87% | 15M | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 110K | SH | $15.69M 1.81% | 110K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 650K | SH | $15.66M 1.81% | 650K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 200K | SH | $15.17M 1.75% | 200K | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 4.30M | SH | $14.96M 1.72% | 4.30M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 375K | SH | $13.57M 1.56% | 375K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 650K | SH | $13.38M 1.54% | 650K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 2.86M | SH | $12.74M 1.47% | 2.86M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 513.42K | SH | $12.07M 1.39% | 513.42K | 0.00 | 0.00 |
ELIEM THERAPEUTICS INCSOLE | COM | 1.67M | SH | $11.88M 1.37% | 1.67M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 400.39K | SH | $10.57M 1.22% | 400.39K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 1.14M | SH | $10.26M 1.18% | 1.14M | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 223.41K | SH | $10.15M 1.17% | 223.41K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 700K | SH | $10.12M 1.17% | 700K | 0.00 | 0.00 |
Page 1 of 4